Elrexfio Injection, Solution
Product Images NDC 63539-252

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Elrexfio (NDC 63539-252). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Elranatamab 01)

Logo (Elranatamab 01)
Pfizer, a pharmaceutical company based in New York, NY, distributes their products through Pfizer Labs, a division of Pfizer Inc.*
FDA Label Image

Logo (Elranatamab 02)

Logo (Elranatamab 02)
Pfizer Labs, a division of Pfizer Inc., is a pharmaceutical company headquartered in New York, NY 10001. They distribute various products.*
FDA Label Image

Principal Display Panel – 44 mg/1.1 mL Vial (Elranatamab 03)

Principal Display Panel – 44 mg/1.1 mL Vial (Elranatamab 03)
Not available*
FDA Label Image

Principal Display Panel – 44 mg/1.1 mL Vial Carton (Elranatamab 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.